World Health Organization vaccine experts said Wednesday the AstraZeneca-Oxford Covid-19 vaccine could be used for people aged over 65, and also in settings where variants of the virus are circulating.
But, he told journalists, “we feel that the response of this group cannot be any different from groups of a younger age”. Alarm was raised when a trial at Johannesburg’s University of Witwatersrand concluded the AstraZeneca vaccine provided only “minimal” protection against mild to moderate Covid-19 caused by the variant.
Cravioto stressed that “there is no reason not to recommend its use even in the countries that have the circulation of the variants”. UK-Swedish pharmaceuticals giant AstraZeneca’s vaccine is currently a vital part of Covax, the system set up by WHO and others to procure Covid-19 jabs and ensure their equitable distribution around the world.
South Africa Latest News, South Africa Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.